Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.

The purpose of our study was to understand if Toll-like receptor 9 (TLR9) activation could contribute to the control of inflammation in Sjogren's syndrome. To this end, we manipulated TLR9 signaling in non-obese diabetic (NOD) and TLR9(-/-) mice using agonistic CpG oligonucleotide aptamers, TLR9 inh...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Adi Gilboa-Geffen, Yochai Wolf, Geula Hanin, Naomi Melamed-Book, Marjorie Pick, Estelle R Bennett, David S Greenberg, Susan Lester, Maureen Rischmueller, Hermona Soreq
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2011-01-01
coleção:	PLoS ONE
Acesso em linha:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22174879/?tool=EBI
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!